Please select the eligibility criteria that correspond to the clinical trial below.
Title: Randomized Control Trial of a Group Therapy Intervention Addressing Body Image and Psychosocial Functioning for Women With Breast Cancer
Brief Summary: The purpose of this study is to test an innovative intervention geared towards issues of identity, body image and sexuality, and to examine the intervention for its impact on body image, quality of life, psychosocial/sexuality/relational functioning.


Options:
A: Inclusion Criteria:

* women with primary breast cancer
* age between 18 and 65 years
* completed adjuvant treatments
* Stage I,II,III cancer of the breast with no metastatic disease

Exclusion Criteria:

* presence of any metastases
* history of major psychiatric disorder as defined by the DSM-IV
* inability to speak or read English for questionnaire completion
* failure to provide informed consent
* currently participating in a therapist-led psychosocial support group
B: Inclusion Criteria

* Patients with a verified cancer diagnosis other than basal cell carcinoma, incl. H\&N cancer
* Sufficient language ability to understand and complete the questionnaires without assistance
* No obvious cognitive impairments, as judged by the study coordinator upon inclusion
* Age 18 years or above
* Provision of written informed consent
* No participation in another trial or study possibly interfering with the present study

Exclusion Criteria:

* Patients being diagnosed with basal cell carcinoma
* Patients who have been included in Phase I-III of the module development
* Patients who are in the terminal phase of cancer
* Patients who are unable to participate in the interviews do to obvious cognitive impairment, psychological disturbance or language problems
C: Inclusion Criteria:

* patients diagnosed with breast cancer after completion of adjuvant chemotherapy or radiation therapy, with/or without endocrine therapy

Exclusion Criteria:

* patients with advanced illness at diagnosis
* patients previously used MBSR
D: Inclusion Criteria:

* having received a diagnosis for a stage I-III cancer within the past 18 months;
* having a score of 7 or higher on the depression subscale of the Hospital Anxiety and Depression Scale (HADS-D)84 or of 14 or higher on the Beck Depression Inventory-II (BDI-II);

Exclusion Criteria:

* have received bright light therapy in the past month or having previously received cognitive therapy for depression;
* having severe cognitive impairments (e.g., diagnosis of Parkinson's disease, dementia, or Mini-Mental State Examination \[MMSE\] score \< 27);
* meeting DSM-IV criteria for a major depressive episode of severe intensity, or another severe psychiatric disorder (e.g., psychotic, bipolar, or substance use disorder);
* presenting suicidal ideations with a risk of acting out, or having attempted suicide in the past five years;
* having started a new psychotropic medication or having modified the dosage or frequency of use during the past two weeks;
* currently taking a photosensitive medication (e.g., lithium, L-tryptophan);
* having evidence of an ocular pathology from an optometrist exam or a medical condition contraindicating the use of bright light therapy (e.g., severe cataracts, glaucoma, diabetes).

Answer: A